08:30:23 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



News for U:CLGN from 2023-05-03 to 2024-05-02 - 16 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-04 07:17U:CLGNNews ReleaseCOLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
2024-04-04 07:00U:CLGNNews ReleaseCOLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
2024-03-26 08:00U:CLGNNews ReleaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
2024-02-15 08:00U:CLGNNews ReleaseCollPlant Issues Letter to Shareholders
2024-01-08 07:18U:CLGNNews ReleaseCollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
2024-01-02 07:00U:CLGNNews ReleaseCollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
2023-11-29 07:00U:CLGNNews ReleaseCollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
2023-11-09 08:00U:CLGNNews ReleaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
2023-11-01 07:05U:CLGNNews ReleaseCollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
2023-09-21 07:00U:CLGNNews ReleaseCollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative
2023-09-05 07:00U:CLGNNews ReleaseCollPlant to Present at the H.C. Wainwright Annual Growth Conference
2023-08-24 07:00U:CLGNNews ReleaseCollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
2023-08-09 09:02U:CLGNNews ReleaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
2023-08-09 08:00U:CLGNNews ReleaseCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
2023-06-26 07:00U:CLGNNews ReleaseCollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement
2023-05-24 07:00U:CLGNNews ReleaseCollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update